Trending...
- Jo Cato Recognized as a 2025 Women Inspiring Nevada Honoree by Vegas Inc
- Blu Dream Studios Welcomes Acclaimed Writer & Producer Michele Cannon to Creative Team
- Phinge CEO Explains the Benefits of Netverse Being Proactive Versus the Reactionary Technology of Today: Our Unwavering Commitment to Security & Trust
FAYETTEVILLE, Ark. - nvtip -- Lineus Medical has obtained CE Mark certification for its flagship product, SafeBreak® Vascular, the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 With this certification, SafeBreak Vascular is now cleared for use across the European Union. This approval expands SafeBreak Vascular's clearance from 5 countries to 32, spanning across more than three continents. Lineus Medical is actively partnering with distributors across Europe to expand hospital access to SafeBreak worldwide.
SafeBreak Vascular is a break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on nvtip.com
"Earning the CE Mark is a major milestone in our company's journey," says Vance Clement, CEO of Lineus Medical. "It reflects our commitment to remove the pains associated with IV lines and make SafeBreak Vascular the standard of care worldwide. Our goal is to be the leading company in this market segment in both science and sales. This clearance affirms that position and makes SafeBreak the first break-away device to have clearance in Asia, Europe, and North America."
Larry Hayes, VP of Sales comments, "With CE Mark approval, we are opening the door to new distribution partnerships across Europe. This certification allows SafeBreak Vascular to reach more hospitals and healthcare systems, accelerating our global commercialization strategy and expanding our global footprint."
"Achieving CE Mark certification is a testament to the quality and reliability of both our product and our manufacturing processes," said Will Armstrong, COO. "It reflects the strength of our team and our commitment to maintaining the highest standards."
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV restarts and IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
SafeBreak Vascular is a break-away device for IV lines clinically proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on nvtip.com
- DAECO Painting Sets the Gold Standard for High-End Interior Painting Services in Denver, CO
- Boston Industrial Solutions Expands Availability of Industry-Leading Primers to Mexico
- Unprescribed™ Introduces the Focus, Mood & Mind System™
- Texas Mechanic Unveils "Mighty Mule" Experimental Pontiac Engine—Delivering Over Triple the Factory Horsepower
- $20 Target in Noble Capital Markets Report Supported by Live Stream of 1ST Global Super League Kerala Event from AI Powered Sports Leader: $SEGG
"Earning the CE Mark is a major milestone in our company's journey," says Vance Clement, CEO of Lineus Medical. "It reflects our commitment to remove the pains associated with IV lines and make SafeBreak Vascular the standard of care worldwide. Our goal is to be the leading company in this market segment in both science and sales. This clearance affirms that position and makes SafeBreak the first break-away device to have clearance in Asia, Europe, and North America."
Larry Hayes, VP of Sales comments, "With CE Mark approval, we are opening the door to new distribution partnerships across Europe. This certification allows SafeBreak Vascular to reach more hospitals and healthcare systems, accelerating our global commercialization strategy and expanding our global footprint."
"Achieving CE Mark certification is a testament to the quality and reliability of both our product and our manufacturing processes," said Will Armstrong, COO. "It reflects the strength of our team and our commitment to maintaining the highest standards."
About Lineus Medical
Lineus Medical is the developer of SafeBreak Vascular, a breakaway technology proven to reduce IV restarts and IV complications.1 Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.
References:
1. Data on File
Source: Lineus Medical
Filed Under: Technology
0 Comments
Latest on nvtip.com
- Assent Recognized as a Leader in First-Ever Product Compliance Green Quadrant
- Tina Glasneck Launches New Romantasy, A Dragon's Queen, Blending Dragons, Fae Courts, and Forbidden Love
- Announcing the "Utsunomiya Gyoza Festival 2025" to be held November 1 and 2 in Utsunomiya City, Tochigi Pref, Japan
- Phinge's Netverse Verified AI Offers the Solution to Hollywood's Gravest Fears Over Likeness & IP Misuse: Actors Writers Directors to Control Their IP
- TradeTek 3.0 Mac and Windows Construction Estimating Software
- Sine Nomine Associates: OpenAFS Google Summer of Code projects have been completed
- HuskyTail Digital Marketing Rings in Fall with Free SEO Audits for Local Businesses
- David White DDS Advances Implant Dentistry with New Technology Acquisition
- Synthera™ Unveils Chameleon™: Creating a new Paradigm in ML training for Computer Vision
- Final Countdown: The OpenSSL Conference 2025 Begins in One Week
- New Frontier Aerospace Appoints Industry Veteran Rich Pournelle as Director of Business Development
- AI's Urgent Energy Requirements Won't Be Solved By Trillions Of Dollars. Phinge's Patented App-Less Netverse Platform & Hardware Will Reduce This Need
- SportsGuruConsulting.com Launches: The Future of Beating Vegas is Here
- New Children's Story Book Spreads Holiday Cheer Through the Joy of Giving
- $750 Million Market Projected to Reach $3.35 Billion; Huge Opportunity for Superior Preservative-Free Ketamine Drug Treating Suicidal Depression $NRXP
- €6.4 Million in Contracts Across Multiple Countries; Smart City Developer; U.S. Expansion, and Announces Strategic Drone Tech Partnership; $AFFU
- CRYPTOCURRENCY: Lucrumia Exchange Platform Addresses Italian Traders' Growing Demand for Secure Digital Asset Trading
- NIUFO Launches Secure Trading Platform for Italian Market Seeking Stability After 20% User Decline
- OrderDomains.com Empowers Businesses with Premium Domains and Flexible Financing